Correlation Between Acumen Pharmaceuticals and Cymabay Therapeu

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Cymabay Therapeu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Cymabay Therapeu into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and Cymabay Therapeu, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Cymabay Therapeu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Cymabay Therapeu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Cymabay Therapeu.

Diversification Opportunities for Acumen Pharmaceuticals and Cymabay Therapeu

-0.02

Correlation Coefficient

Acumen Pharmaceuticals  Cymabay Therapeu

Good diversification

The 3 months correlation between Acumen and Cymabay is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Cymabay Therapeu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cymabay Therapeu and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Cymabay Therapeu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cymabay Therapeu has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Cymabay Therapeu go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Cymabay Therapeu

If you would invest  1,183  in Cymabay Therapeu on October 26, 2024 and sell it today you would earn a total of  0.00  from holding Cymabay Therapeu or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	5.26%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  Cymabay Therapeu

Acumen Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cymabay Therapeu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cymabay Therapeu has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Cymabay Therapeu is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Acumen Pharmaceuticals and Cymabay Therapeu

The main advantage of trading using opposite Acumen Pharmaceuticals and Cymabay Therapeu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Cymabay Therapeu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cymabay Therapeu will offset losses from the drop in Cymabay Therapeu's long position.

The idea behind Acumen Pharmaceuticals and Cymabay Therapeu pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.